Table 1

Mean choroidal thickness in pretreated and treatment-naive patients prior to and after a loading dose of three 2 mg aflibercept injections at 4 weeks interval

Retinal area	Pretreated patients mean choroidal thickness			Treatment-naive patients mean choroidal thickness
Retinal area	Before	After	p Value	Before	After	p Value
2500NCT	112.4±49.7	104.8±49.4	<0.001	125.3±52.1	110.0±41.2	<0.001
300NCT	173.7±58.2	164.9±56.8	<0.001	218.7±69.2	196.3±71.2	<0.001
SFCT	182.8±57.4	172± 57.7	<0.001	226.4±68.5	208.0±66.6	<0.001
300TCT	173.6±57.5	163.7±56.2	<0.001	225.7±71.1	209.3±68.8	<0.001
2500TCT	176.2±55.1	165.5±54.6	<0.001	213.9±71.3	195.7±78.5	<0.001

2500NCT=choroidal thickness 2500 µm nasal from the central fovea, 300NCT=choroidal thickness 300 µm nasal from the central fovea, SFCT=subfoveal choroidal thickness, 300TCT=choroidal thickness 300 µm temporal from the central fovea, 2500TCT=choroidal thickness 2500 µm temporal from the central fovea.
Data presented as mean±SD.